1
Cogan Derek, Hao Ming Hong, Kamhi Victor Marc, Miller Craig Andrew, Netherton Matthew Russell, Swinamer Alan David: 3-‘4-heterocyclyl -1,2,3,-triazol-1-yl!-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases. Boehringer Ingelheim Pharmaceuticals, Cogan Derek, Hao Ming Hong, Kamhi Victor Marc, Miller Craig Andrew, Netherton Matthew Russell, Swinamer Alan David, MORRIS Michael P, September 29, 2005: WO/2005/090333 (8 worldwide citation)

Disclosed compounds of formula (I), which inhibit production of cytokines involved in inflammatory processes and are thus useful for treating diseases and pathological conditions involving inflammation such as chronic inflammatory disease. Also disclosed are processes for preparing these compounds a ...


2
Cogan Derek, Hao Ming Hong, Aungst Ronald A, Swinamer Alan David: Anti-cytokine heterocyclic compounds. Boehringer Ingelheim Pharmaceuticals, Cogan Derek, Hao Ming Hong, Aungst Ronald A, Swinamer Alan David, MORRIS Michael P, December 8, 2005: WO/2005/115991 (7 worldwide citation)

Disclosed are compunds of formula (I). The compounds inhibit production of cytokines involved in inflammatory processes and are thus useful for treating diseases and pathological conditions involving inflammation such as chronic inflammatory disease. Also disclosed are processes for preparing these ...


3

4

5
Breitfelder Steffen, Cirillo Pier F, Hao Ming Hong, Hickey Eugene R, Sharma Rajiv, Sun Sanxing, Takahashi Hidenori: Urea derivatives as anti-inflammatory agents. Boehringer Ingelheim Pharmaceuticals, Breitfelder Steffen, Cirillo Pier F, Hao Ming Hong, Hickey Eugene R, Sharma Rajiv, Sun Sanxing, Takahashi Hidenori, RAYMOND Robert, May 25, 2001: WO/2001/036403 (2 worldwide citation)

Disclosed are novel aromatic compounds of formula (I) wherein G, X, Ar, L and Q are defined herein. The compounds are useful in pharmaceutic compositions for treating diseases or pathological conditions involving inflammation such as chronic inflammatory diseases. Also disclosed are processes of mak ...


6
Cogan Derek, Goldberg Daniel R, Hao Ming Hong, Xiong Zhaoming, Aungst Ronald A, Davis Amy L: Cytokine inhibitors. Boehringer Ingelheim Pharmaceuticals, Cogan Derek, Goldberg Daniel R, Hao Ming Hong, Xiong Zhaoming, Aungst Ronald A, Davis Amy L, MORRIS Michael P, November 17, 2005: WO/2005/108387 (1 worldwide citation)

Disclosed are compounds of formula (I) which inhibit production of cytokines involved in inflammatory processes and are thus useful for treating diseases and pathological conditions involving inflammation such as chronic inflammatory disease. Also disclosed are processes for preparing these compound ...